Related Articles
Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy
Absolute lymphocyte count and C‑reactive protein‑albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy
Change in the neutrophil‑to‑lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer
Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer
Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters